Divis Laboratories Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹3,080.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.80 per cent from ₹2,831.00 crore. This corresponds to a year-on-year *(YoY) growth of 27.80 per cent.

Operating Profit

Operating Profit stands at ₹1,255.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.37 per cent from ₹934.00 crore. This corresponds to a year-on-year *(YoY) growth of 72.15 per cent.

PBDT

PBDT stands at ₹1,313.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,083.00 crore. This corresponds to a year-on-year *(YoY) growth of 55.38 per cent.

Profit Before Tax

Profit Before Tax stands at ₹1,180.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.53 per cent from ₹963.00 crore. This corresponds to a year-on-year *(YoY) growth of 60.98 per cent.

Net Profit

Net Profit stands at ₹902.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.11 per cent from ₹751.00 crore. This represents a 65.50 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Divis Laboratories Ltd Earnings

CategoryQ1 FY26-27Q1 FY25-26Change %FY25-26FY24-25Change %
Total Revenue3,080.002,410.0027.8010,560.009,360.0012.82
Expenses1,825.001,681.008.577,193.006,392.0012.53
Other Income64.00119.00-46.22507.00352.0044.03
Operating Profit1,255.00729.0072.153,874.003,320.0016.69
Depreciation133.00112.0018.75463.00402.0015.17
Interest6.003.00100.0023.002.001050.00
Profit Before Tax1,180.00733.0060.983,388.002,916.0016.19
Tax278.00188.0047.87868.00799.008.64
Net Profit902.00545.0065.502,568.002,191.0017.21
CategoryQ1 FY26-27Q4 FY25-26Change %
Total Revenue3,080.002,831.008.80
Expenses1,825.001,897.00-3.80
Other Income64.00155.00-58.71
Operating Profit1,255.00934.0034.37
Depreciation133.00120.0010.83
Interest6.006.000.00
Profit Before Tax1,180.00963.0022.53
Tax278.00212.0031.13
Net Profit902.00751.0020.11

Divis Laboratories Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 7,375Sharekhan11-Dec-2025
Neutral 6,925Motilal Oswal10-Nov-2025
Neutral 6,320Motilal Oswal07-Aug-2025
Buy 7,225Edelweiss Securities19-May-2025
Neutral 6,200Motilal Oswal04-Feb-2025

Divis Laboratories Ltd Financial Reports

Data not available.

Divis Laboratories Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Divi's Lab.-0.58%-1.16%14.61%25.74%32.85%36.07%
Sun Pharma.Inds.0.47%1.79%-3.22%3.73%8.28%15.28%
Torrent Pharma.-0.40%-2.29%-3.11%6.32%9.98%32.42%
Cipla0.62%0.22%1.78%1.52%6.64%-10.37%
Zydus Lifesci.-1.70%-1.43%-0.63%2.60%19.75%7.58%

Divis Laboratories Ltd Corporate Information

Chairman & Independent Directo: Ramesh B V Nimmagadda
Executive Director & MD: Murali K Divi
Executive Director: N V Ramana
Executive Director / Whole Time Director / CEO: Kiran S Divi
ED / WTD - Commercial: Nilima Prasad Divi
Executive Director / Whole Time Director: S. Devendra Rao
Independent Non Exe. Director: S Ganapaty
Independent Non Exe. Director: Sunaina Singh
Independent Non Exe. Director: Kosaraju Veerayya Chowdary
Independent Non Exe. Director: Rajendrakumar Premchand Shah
Company Sec. & Compli. Officer: Satish Choudhury

Divis Laboratories Ltd News

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Updated On: 06 Apr 2026 | 11:19 AM IST
More